Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Liabilities and Shareholders Equity: 2023-2024

Historic Liabilities and Shareholders Equity for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $481.7 million.

  • Upstream Bio's Liabilities and Shareholders Equity rose 68.11% to $391.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year change of. This contributed to the annual value of $481.7 million for FY2024, which is 311.03% up from last year.
  • According to the latest figures from FY2024, Upstream Bio's Liabilities and Shareholders Equity is $481.7 million, which was up 311.03% from $117.2 million recorded in FY2023.
  • Over the past 5 years, Upstream Bio's Liabilities and Shareholders Equity peaked at $481.7 million during FY2024, and registered a low of $117.2 million during FY2023.
  • In the last 2 years, Upstream Bio's Liabilities and Shareholders Equity had a median value of $299.5 million in 2023 and averaged $299.5 million.
  • Data for Upstream Bio's Liabilities and Shareholders Equity shows a peak YoY skyrocketed of 311.03% (in 2024) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Liabilities and Shareholders Equity (Yearly) stood at $117.2 million in 2023, then skyrocketed by 311.03% to $481.7 million in 2024.